What Is Monobenzone Cream? Uses, Benefits, Side Effects & Safety

What Is Monobenzone Cream?

Monobenzone cream is a prescription pharmaceutical topical cream used for permanent skin depigmentation in patients with extensive vitiligo. The active ingredient, monobenzone (monobenzyl ether of hydroquinone, or MBEH), permanently destroys melanocytes — the cells responsible for producing skin pigment (melanin) — through free radical generation and tyrosinase inhibition. Unlike hydroquinone, which only suppresses pigment temporarily, monobenzone's effect is irreversible: once melanocytes are destroyed, they do not regenerate. Monobenzone has been FDA-approved since 1952 specifically for this indication, making it one of the longest-standing dermatological approvals in history. It was originally marketed under the brand name Benoquin by ICN/Valeant Pharmaceuticals, discontinued for commercial reasons in the years since. Today, the widely available pharmaceutical-grade equivalent is Monozan® by Behvazan Pharmaceutical Co. (Rasht, Iran), containing the identical active ingredient at the same 20% concentration.

What Is Monobenzone Used For?

Monobenzone cream is indicated for one specific medical purpose:

• Permanent depigmentation in extensive vitiligo — patients with vitiligo covering 50% or more of body surface area who have decided to achieve a uniform, depigmented skin appearance

It is not indicated for:

• Cosmetic skin lightening or bleaching
• Melasma or age spot treatment (hydroquinone is more appropriate)
• Limited or early-stage vitiligo (repigmentation therapies are first-line)
• Any use in children under 12 without specialist guidance

How Does Monobenzone Work?

Monobenzone works through two complementary mechanisms that together produce permanent melanocyte destruction:

1. Free Radical Generation

Monobenzone is oxidized by tyrosinase — an enzyme inside melanocytes — generating quinone free radicals. These free radicals selectively destroy the melanocytes from within, permanently eliminating their ability to produce pigment.

2. Tyrosinase Inhibition

Simultaneously, monobenzone inhibits tyrosinase directly — blocking the primary enzymatic pathway responsible for melanin biosynthesis. This dual action makes monobenzone significantly more potent than hydroquinone, which only inhibits tyrosinase without destroying the cells themselves.

The net result is permanent, irreversible depigmentation of treated areas. Unlike hydroquinone (where pigment returns when treatment stops), monobenzone's effects are permanent because the pigment-producing cells themselves are eliminated.

Monobenzone Cream — Key Specifications

Benefits of Monobenzone Cream

For appropriately selected vitiligo patients, monobenzone cream offers several significant clinical benefits:

• Permanent uniform appearance: Creates a consistent skin tone by removing remaining pigmented areas to match existing vitiligo patches
• Clinically proven: Results documented in peer-reviewed literature (PMC3533321, 2012) with stability confirmed at 3-year follow-up
• FDA-approved mechanism: 70+ year safety record for its approved indication
• Multiple concentration options: 20%, 40%, and 60% allow individualized treatment intensity
• Psychological benefit: Many patients report significant improvement in quality of life and self-confidence after achieving a uniform skin appearance

Treatment Timeline — What to Expect

Side Effects of Monobenzone Cream

The most common side effects are manageable and expected during the initial phase of treatment:

• Skin redness and irritation (30–50% of patients) — typically reduces after the first few weeks
• Itching (pruritus) — manage with antihistamines and reducing application frequency temporarily
• Increased sun sensitivity — permanent after treatment; SPF 50+ mandatory for life
• Contact dermatitis — uncommon; stop use and consult a dermatologist

Who Should and Should Not Use Monobenzone?

Suitable candidates:

• Adults with vitiligo covering 50%+ of body surface area
• Patients for whom repigmentation therapy has failed
• Patients who have made an informed, permanent decision about depigmentation
• Patients under qualified dermatologist supervision

Not suitable for:

• Patients with limited vitiligo (under 50% coverage)
• Pregnant or breastfeeding women (without explicit physician guidance)
• Children under 12 (without specialist supervision)
• Cosmetic skin lightening without a medical indication

Monobenzone Cream Concentrations Available

• 20% — Standard strength, equivalent to original Benoquin. Starting concentration for most patients. From $12 at GulfDermaCare.
• 40% — Double strength, produces faster results. Recommended after tolerance assessment with 20%. 100g tube, $55.
• 60% — Maximum strength for advanced or resistant cases. Physician supervision mandatory. 100g tube, $75.

Where to Buy Monobenzone Cream

Since Benoquin was discontinued, sourcing genuine pharmaceutical-grade monobenzone cream has become challenging. GulfDermaCare supplies original Monozan® by Behvazan Pharmaceutical Co. with:

• Certificate of Analysis with every order
• Original pharmaceutical packaging
• Free shipping via UPS & FedEx to Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain and worldwide
• WhatsApp ordering at +923174900576

Medical References & Sources

This article is written to align with published dermatological literature and official prescribing information. Primary sources you can review directly:

• Benoquin (Monobenzone) — FDA-approved prescribing information: drugs.com/pro/benoquin.html
• DermNet NZ — Depigmentation therapy for vitiligo: dermnetnz.org
• American Academy of Dermatology — Vitiligo: Diagnosis and Treatment: aad.org
• PubMed / NCBI — peer-reviewed research on monobenzone and vitiligo: pubmed.ncbi.nlm.nih.gov

GulfDermaCare is a pharmaceutical supplier, not the author of these studies — we link to them so you and your dermatologist can review the primary evidence directly.

Frequently Asked Questions